Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vedran Radojcic

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
The Journal of Clinical Investigation|September 13, 2022
Immune dysfunction signatures predict outcomes and define checkpoint blockade-unresponsive microenvironments in acute myeloid leukemiaSergio Rutella, Jayakumar Vadakekolathu, Francesco Mazziotta, et al.
Blood|February 3, 2021
BAFF promotes heightened BCR responsiveness and manifestations of chronic GVHD after allogeneic stem cell transplantationWei Jia, Jonathan C Poe, Hsuan Su, et al.
The New England Journal of Medicine|September 18, 2024
Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host DiseaseDaniel Wolff, Corey Cutler, Stephanie J Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 2, 2022
Axatilimab for Chronic Graft-Versus-Host Disease After Failure of at Least Two Prior Systemic Therapies: Results of a Phase I/II StudyCarrie L Kitko, Mukta Arora, Zachariah DeFilipp, et al.
The Journal of Clinical Investigation|March 21, 2017
Fibroblastic niches prime T cell alloimmunity through Delta-like Notch ligandsJooho Chung, Christen L Ebens, Eric Perkey, et al.
Transplantation and Cellular Therapy|July 4, 2021
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms reportDaniel Wolff, Vedran Radojcic, Robert Lafyatis, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
The Journal of Clinical Investigation|September 13, 2022
Immune dysfunction signatures predict outcomes and define checkpoint blockade-unresponsive microenvironments in acute myeloid leukemiaSergio Rutella, Jayakumar Vadakekolathu, Francesco Mazziotta, et al.
Blood|February 3, 2021
BAFF promotes heightened BCR responsiveness and manifestations of chronic GVHD after allogeneic stem cell transplantationWei Jia, Jonathan C Poe, Hsuan Su, et al.
The New England Journal of Medicine|September 18, 2024
Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host DiseaseDaniel Wolff, Corey Cutler, Stephanie J Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 2, 2022
Axatilimab for Chronic Graft-Versus-Host Disease After Failure of at Least Two Prior Systemic Therapies: Results of a Phase I/II StudyCarrie L Kitko, Mukta Arora, Zachariah DeFilipp, et al.
The Journal of Clinical Investigation|March 21, 2017
Fibroblastic niches prime T cell alloimmunity through Delta-like Notch ligandsJooho Chung, Christen L Ebens, Eric Perkey, et al.
Transplantation and Cellular Therapy|July 4, 2021
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms reportDaniel Wolff, Vedran Radojcic, Robert Lafyatis, et al.
Pageof 3